UTX-143 is an inhibitor of Na+/H+ exchange protein (NHE5). UTX-143 has antitumor activity[1].

UTY Human Pre-designed siRNA Set A contains three designed siRNAs for UTY gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UVRAG Human Pre-designed siRNA Set A contains three designed siRNAs for UVRAG gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UVSSA Human Pre-designed siRNA Set A contains three designed siRNAs for UVSSA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UWA-101 hydrochloride is a selective and non-cytotoxic DAT/SERT inhibitor, with EC50 values of 3.6 µM and 2.3 µM for inhibiting DAT and SERT, respectively. UWA-101 hydrochloride can alleviate the side effects of dopaminergic agents (such as L-DOPA), such as motor disorders, and lacks psychotropic activity. UWA-101 hydrochloride can be used for research on neurodegenerative diseases […]

UXS1 Human Pre-designed siRNA Set A contains three designed siRNAs for UXS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

UXT Human Pre-designed siRNA Set A contains three designed siRNAs for UXT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAC14 Human Pre-designed siRNA Set A contains three designed siRNAs for VAC14 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Val-Ala-PAB is a cleavable ADC linker that can be used for ADCs synthesis[1].

Val-Ala-PAB is a cleavable ADC linker that can be used for ADCs synthesis[1].

Val-Cit-PAB-DEA-COOH (compound 17) is an ADC linker that can be used in the synthesis of ADCs[1].

Val-Cit-PAB-DEA-Dxd (compound 81) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule Dxd (DNA topoisomerase I inhibitor). Val-Cit-PAB-DEA-Dxd can be used for ADC synthesis[1].

Valacyclovir (hydrochloride) (Standard) is the analytical standard of Valacyclovir (hydrochloride). This product is intended for research and analytical applications. Valacyclovir hydrochloride (Valaciclovir hydrochloride) is an orally active antiviral agent for herpes simplex, herpes zoster, and herpes B. Valacyclovir hydrochloride inhibits HSV-1 W (50=2.9 μg/ml). Valacyclovir hydrochloride is a proagent of Aciclovir (HY-17422) [1][2][3][4][5].

Valerena-4,7(11)-diene is a tranquilizer. Valerena-4,7(11)-diene suppresses stress-induced excitatory behaviors. Valerena-4,7(11)-diene is expressed via olfactory stimulation and pulmonary absorption[1].

Valganciclovir (hydrochloride) (Standard) is the analytical standard of Valganciclovir (hydrochloride). This product is intended for research and analytical applications. Valganciclovir hydrochloride is an orally active antiviral agent. Valganciclovir hydrochloride can inhibit the growth of adenoviruses and have a protective effect on immunosuppressed hamsters. Valganciclovir hydrochloride can be used for the research of Cytomegalovirus[1][2][3].

Valnemulin is an orally active broad-spectrum antibiotic against Gram-negative and Gram-positive bacteria, anaerobic bacteria, Mycoplasma, and Spirochetes. Valnemulin ameliorates enteric diseases, acute polyarthritis and enzootic pneumonia in pigs[1]. Valnemulin exhibits anti-inflammatory efficacy against lipopolysaccharide (HY-D1056)-induced lung injury[2].

Valnemulin (hydrochloride) (Standard) is the analytical standard of Valnemulin (hydrochloride). This product is intended for research and analytical applications. Valnemulin hydrochloride is a pleuromutilin antibiotic which inhibits protein synthesis in bacteria by binding the peptidyl transferase enzyme in the 50s ribosomal subunit.

Valsartan (Standard) is the analytical standard of Valsartan. This product is intended for research and analytical applications. Valsartan (CGP 48933) is an angiotensin II receptor antagonist and has the potential for high blood pressure and heart failure research[1].

VAMP1 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP2 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP3 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP4 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP5 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP7 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAMP8 Human Pre-designed siRNA Set A contains three designed siRNAs for VAMP8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VANGL1 Human Pre-designed siRNA Set A contains three designed siRNAs for VANGL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VANGL2 Human Pre-designed siRNA Set A contains three designed siRNAs for VANGL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vanillylmandelic acid (Standard) is the analytical standard of Vanillylmandelic acid. This product is intended for research and analytical applications. Vanillylmandelic acid is the endproduct of epinephrine and norepinephrine metabolism. Vanillylmandelic acid can be used as an indication of the disorder in neurotransmitter metabolism as well. Vanillylmandelic acid has antioxidant activity towards DPPH radical with an […]

Vanin-1-IN-4 (compound (S)-1) is vanin-1 inhibitor with a chiral methyl substituent, with profils as potent drug-candidate but exist as an amorphous solid[1].

VAPA Human Pre-designed siRNA Set A contains three designed siRNAs for VAPA gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VAPB Human Pre-designed siRNA Set A contains three designed siRNAs for VAPB gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vardenafil-d5 hydrochloride is deuterated labeled Vardenafil hydrochloride (HY-B0442A). Vardenafil hydrochloride is a selective and orally active inhibitor of phosphodiesterase-5 (PDE5), with an IC50 of 0.7 nM. Vardenafil hydrochloride shows inhibitory towards PDE1, PDE6 with IC50s of 180 nM, and 11 nM, while IC50s are >1000 nM for PDE3 and PDE4[1]. Vardenafil hydrochloride competitively inhibits cyclic […]

Varenicline-15N,13C,d2 is 15N and deuterated labeled Varenicline (HY-10019). Varenicline (CP 526555) is an orally active partial agonist of α4β2 nicotinic acetylcholine receptor (α4β2 nAChR, IC50=250 nM), which is the principal mediator of nicotine dependence. Varenicline is also a partial agonist of α6β2 nAChR and a full agonist of α6β2 nAChR. Varenicline blocks the direct agonist […]

VARS1 Human Pre-designed siRNA Set A contains three designed siRNAs for VARS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VARS2 Human Pre-designed siRNA Set A contains three designed siRNAs for VARS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VASH1 Human Pre-designed siRNA Set A contains three designed siRNAs for VASH1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VASH2 Human Pre-designed siRNA Set A contains three designed siRNAs for VASH2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

VASN Human Pre-designed siRNA Set A contains three designed siRNAs for VASN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vasopressin V2 receptor antagonist 2 (Compound 33) is an antagonist of the arginine vasopressin V2 receptor (V2R) with a Ki value of 6.2 nM. Vasopressin V2 receptor antagonist 2 can effectively reduce cAMP levels, thereby inhibiting the growth of renal cysts[1].

VASP Human Pre-designed siRNA Set A contains three designed siRNAs for VASP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Vat Black 25 is a black dye.

Vat Black 27 is a black dye.

Vat Black 8 is a black dye.

Vat Brown 1 is a brown dye.

Vat Red 10 is a red dye.

Vat Red 15 is a red dye.

Vat violet 13 is a violet dye.